Activation of adenosine A2α receptors inhibits mast cell degranulation and mast cell-dependent vasoconstriction

Microcirculation

Volumn 7, Issue 2, 2000, Pages 129-135

  Fenster, M S ^a   Shepherd, R K ^b   Linden, J ^a   Duling, Brian R ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine; Arterioles; Inosine; Mast cell; Microcirculation

Indexed keywords

CRICETINAE; MESOCRICETUS AURATUS;

ADENOSINE; ADENOSINE RECEPTOR; INOSINE; THEOPHYLLINE; VASODILATOR AGENT;

ANIMAL; ARTICLE; DRUG EFFECT; DRUG POTENTIATION; HAMSTER; HISTAMINE RELEASE; MAST CELL; MICROCIRCULATION; PHYSIOLOGY; SYRIAN HAMSTER; VASOCONSTRICTION;

ADENOSINE; ANIMALS; CRICETINAE; HISTAMINE RELEASE; INOSINE; MAST CELLS; MESOCRICETUS; MICROCIRCULATION; RECEPTORS, PURINERGIC P1; THEOPHYLLINE; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 0034170088     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mn.7300101     Document Type: Article

References (26)

1. Abd-Elfattah AS, Jessan ME, Hanan SA, Tuchy G, and Wechsler AS. (1990). Is adenosine 5′ triphosphate derangement or free radical-mediated injury the major cause of ventricular dysfunction during reperfusion. Role of adenine nucleoside transport in myocardial reperfusion injury. Circulation 82(suppl IV):IV341-IV350.
2. Andy RJ and Kornfeld R. (1982). The adenosine deaminase binding protein of human skin fibroblasts is located on the cell surface. J Biol Chem 257:7922-7925.
3. Belardinelli L, Linden J, and Berne R. (1989). The cardiac effects of adenosine. Prog Cardiovasc Dis 32: 73-97.
4. Czarnecki W, Mathison R, Harmsen E, and Tyberg JV. (1992). Inosine - a natural modulator of contractility and myocardial blood flow in the ischemic heart? Am Heart J 124:1446-1459.
5. Doyle MP, Linden J, and Duling BR. (1994). Nucleoside-induced arteriolar constriction: a mast cell-dependent response. Am J Physiol 266:H2042-H2050.
6. Duling B. (1973). The preparation and use of the hamster cheek pouch for studies of the microcirculation. Microvasc Res 5:423-429.
7. Hoffmeister HM, Betz R, Fiechtner H, and Seipel L. (1987). Myocardial and circulatory effects of inosine. Cardiovas Res 21:65-71.
8. Hughes PJ, Holgate ST, Church MK. (1984). Adensoine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism. Biochem Pharmacol 33:3847-3852.
9. Jacobsen, K. (1996). Specific Ligands for the Adenosine Receptor Family. RBI Neurotransmissions 12: 1-2.
10. Jin X, Shepherd RK, Duling, BR, Linden, J. (1997). Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. J Clin Invest 100:2849-2857.
11. Jones CE, Thomas JX, Devous MD, Norris CP, and Smith EE. (1977). Positive inotropic response to inosine in the in situ canine heart. Am J Physiol 233:H438-H443.
12. Manfredi JP and Holmes EW. (1985). Purine salvage pathways in the myocardium. Anna Rev Physiol 47: 691-705.
13. Meghji P, Middleton KM, and Newby AC. (1986). Evidence for extracellular deamination of adenosine in the rat but not the guinea pig heart. Pflugers Arch 407(suppl 1):551 (abstract).
14. Newby AC. (1986). How does dipyridamole elevate extracellular adenosine? Biochem J 237:845-851.
15. Nolte D, Lorenzen A, Lehr HA, Zimmer FJ, Klotz KN, Messmer, K. (1992). Reduction of post ischemic leukocyte-endothelium interaction by adenosine via A2 receptor. Naunyn Schmiedebergs Arch Pharmacol 346:234-237.
16. Ott I, Lohse MJ, Klotz K-N, Vogt-Moykopf I, Schwabe, U. (1982). Effects of adenosine on histamine release from human lung fragments. Int Arch Allergy Immunol 98:50-56.
17. Powers FM, Sobotka PA, and Thomas JX, Jr. (1990). Effects of inosine in the normal and reperfused rat heart. J Cardiovasc Pharmacol 15:862-867.
18. Prewit RL and Sullivan JM. (1980). Vasoactivity of inosine in the rat. Pharmacological Research Communications 12:205-213.
19. Sakai K, Akima M. (1978). Vasoconstriction after adenosine and inosine in the rat isolated hindlimb abolished by blockade of tryptaminergic mechanisms. Naunyn Schmiedebergs Arch Pharrnacol 302:55-59.
20. Seesko RC, Zimmer HG. (1990). Hemodynamic effects of inosine in combination with positive and negative inotropic drugs: study of rats in vivo. J Cardiovasc Pharmacol 16:249-256.
21. Shepherd RK, Duling BR. (1995). Use of ruthenium red staining to detect mast cell degranulation in vivo. Microcirculation 2:363-370.
22. Shepherd RK, Duling BR. (1996). Inosine-induced vasoconstriction is mediated by histamine and thromboxane derived from mast cells. Am J Physiol 270:H560-H566.
23. Shepherd RK, Linden J, Duling BR. Adenosine-induced vasoconstriction in vivo. Role of the mast cell and A3 aderiosine receptor. Circ Res 78(4):627-634.
24. VanDer Meer P, DeJong JW. (1990). Inosirie transiently decreases coronary flow but potentiates vasodilation by adenosine. Am J Physiol 259:H759-H765.
25. Woollard KV, Kingaby RO, Lab MJ, Cole AWG, Palmer TN. (1981). Inosine as a selective inotropic agent on ischaemic myocardium? Cardiovasc Res 21: 659-667.
26. Yang X, Zhu Q, Claydon MA, Micks GL, Jr., Wang T. (1994). Enhanced functional preservation of cold stored rat heart by a nucleoside transport inhibitor. Transplantation 58:28-34.